LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D

• Seth J. Baum,
• Stephen A. Harrison,
• Nadege T. Gunn,
• Ziad H. Younes,
• Anita Kohli,
• Rashmee Patil,
• Juan P. Fras,
• Michael Hamill,
• Nadine Daou,
• Jeff Zhao,
• Manu V. Chakravarthy,
• Margaret J. Koziel

Affiliations

Seth J. Baum

Excel Medical Clinical Trials, Boca Raton, FL, United States

Stephen A. Harrison

Pinnacle Clinical Research, Live Oak, TX, United States

Nadege T. Gunn

Pinnacle Clinical Research, Austin, TX, United States

Ziad H. Younes

Gastro One, Germantown, TN, United States

Anita Kohli

Arizona Liver Health, Chandler, AZ, United States

Rashmee Patil

South Texas Research Institute, Edinburg, TX, United States

Juan P. Fras

National Research Institute, Los Angeles, CA, United States

Michael Hamill

Axcella Health Inc., Cambridge, MA, United States

Nadine Daou

Axcella Health Inc., Cambridge, MA, United States

Jeff Zhao

Axcella Health Inc., Cambridge, MA, United States

Manu V. Chakravarthy

Axcella Health Inc., Cambridge, MA, United States

Margaret J. Koziel

Axcella Health Inc., Cambridge, MA, United States